(Q39537428)

12 September 2017

Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine (English)

1 reference

12 September 2017

visceral leishmaniasis

1 reference

H W Murray

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

44

1 reference

12 September 2017

11

1 reference

12 September 2017

3235-3236

1 reference

Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Kala-azar as an AIDS-related opportunistic infection

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Trial of oral miltefosine for visceral leishmaniasis

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Leishmania and human immunodeficiency virus coinfection: the first 10 years

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Clinical spectrum of Leishmaniasis

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Visceral leishmaniasis in patients infected with the human immunodeficiency virus

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Antithymocyte serum suppression of immunity in mice immunized to Leishmania donovani

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Is leishmaniasis ever cured?

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Models of relapse of experimental visceral leishmaniasis

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=101643

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11036063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral treatment of visceral leishmaniasis with miltefosine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11036063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.44.11.3235-3236.2000

1 reference

release_by7ijmev2bhgpma6qh43pht5lu

12 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/by7ijmev2bhgpma6qh43pht5lu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 September 2017

PubMed publication ID

11036063

1 reference